Rejûvaskin Discloses Trimester-Specific Stretch Mark Cream Protocol
Just another WordPress site
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
NEW YORK – November 17, 2026 – Rejûvaskin, a physician-recommended skincare company producing clinically-formulated creams for scar management, radiation skin relief, sun protection, and sensitive skin, today disclosed the application protocol behind its Stretch Mark Cream. The protocol separates guidance by stage: first, second, and third trimester, and the postpartum recovery window, reflecting how skin elasticity and hydration needs shift as pregnancy progresses and recedes. Rejûvaskin sells its skincare line in more than 80 countries through physician offices, hospital systems, and authorized distributors, and the company is publishing the protocol to standardize how patients and providers discuss stretch mark prevention and recovery care.
Most stretch mark products on the market carry a single generic instruction — apply twice daily — regardless of trimester, skin stretch rate, or postpartum healing stage. Pregnant and postpartum patients routinely ask oncology-adjacent and OB-GYN providers how application should change as the belly, hips, and chest expand and then contract, and providers have lacked a stage-specific standard to hand patients. Rejûvaskin’s decision to publish a structured protocol, rather than leave application guidance to label shorthand, follows the same physician-facing approach the company uses for its radiation relief and scar management lines.
“Patients ask their providers when to start, how often to apply, and whether anything changes after delivery, and most labels don’t answer that,” a Rejûvaskin spokesperson said. “Publishing the protocol gives providers a consistent answer they can repeat across every stage instead of a single generic instruction.”
Trimester-specific application protocol
The protocol calls for earlier, lighter application in the first trimester, when skin stretch is minimal but hydration habits are easiest to establish, moving to heavier, more frequent application through the second and third trimesters as the skin stretches fastest. Rejûvaskin frames this as aligning product use with the body’s actual rate of change rather than a flat daily instruction that ignores which trimester a patient is in.
Postpartum transition guidance
The postpartum section addresses a stage most stretch mark products ignore entirely: skin retraction after delivery. Rejûvaskin’s guidance continues application through the postpartum weeks as skin tightens back toward its pre-pregnancy state, rather than stopping use at delivery, which the company says is when many patients mistakenly discontinue a product.
Physician and distributor access standard
Rejûvaskin distributes its full skincare line, including Stretch Mark Cream, through physician offices, hospital systems, and authorized international distributors across more than 80 countries. The company says publishing the protocol through these same physician-facing channels keeps the guidance consistent regardless of which country or provider a patient is working with.
“We built this protocol the same way we built our radiation relief guidance for oncology nurses — stage by stage, not one instruction for the whole experience,” the Rejûvaskin team noted. “Pregnancy skin changes in phases, and the guidance should change with it.”
How the protocol was compiled
The trimester and postpartum staging reflects standard dermatological understanding of skin elasticity changes across pregnancy and the postpartum recovery window, cross-checked against Rejûvaskin’s existing physician-facing material for its scar management and radiation relief product lines to keep terminology and application guidance consistent across the company’s full catalog.
About Rejûvaskin
Rejûvaskin produces clinically-formulated, physician-recommended skincare for scar management, radiation skin relief, sun protection, and sensitive skin, including its Stretch Mark Cream for pregnancy and postpartum skin, its Skin Recovery Cream line for radiation and OTC scar relief, and its silicone scar sheeting kits for post-surgical recovery. The company’s products are sold in more than 80 countries through physician offices, hospital systems, and authorized distributors, with formulations developed for use by oncology nurses, dermatologists, and OB-GYN providers as well as direct consumers. Rejûvaskin’s product guidance is built around specific skin conditions rather than general beauty claims, pairing each formulation with a defined use case: scar management, radiation relief, sun care, or sensitive and stretching skin. Website: rejuvaskin.com
Media Contact
Company Name: Rejûvaskin
Contact Person: Press
Email: Send Email
Phone: +1 727-535-0022
Address:9843 18th Street North, Suite 160
City: St. Petersburg
State: FL
Country: United States
Website: https://rejuvaskin.com
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Rejûvaskin Discloses Trimester-Specific Stretch Mark Cream Protocol
Media gallery


